GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baird Medical Investment Holdings Ltd (NAS:BDMD) » Definitions » YoY EPS Growth

BDMD (Baird Medical Investment Holdings) YoY EPS Growth : 84.85% (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Baird Medical Investment Holdings YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Baird Medical Investment Holdings's YoY EPS Growth for the quarter that ended in Jun. 2024 was 84.85%.

Baird Medical Investment Holdings's Earnings per Share (Diluted) for the six months ended in Jun. 2024 was $0.12.

Baird Medical Investment Holdings YoY EPS Growth Historical Data

The historical data trend for Baird Medical Investment Holdings's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baird Medical Investment Holdings YoY EPS Growth Chart

Baird Medical Investment Holdings Annual Data
Trend Dec21 Dec22 Dec23
YoY EPS Growth
- 24.56 -16.34

Baird Medical Investment Holdings Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24
YoY EPS Growth - - - - 84.85

Baird Medical Investment Holdings YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Baird Medical Investment Holdings's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EPS Growth (A: Dec. 2023 )
=(Earnings per Share (Diluted) (A: Dec. 2023 )-Earnings per Share (Diluted) (A: Dec. 2022 ))/ | Earnings per Share (Diluted) (A: Dec. 2022 ) |
=(0.297-0.355)/ | 0.355 |
=-16.34 %

Baird Medical Investment Holdings's YoY EPS Growth for the quarter that ended in Jun. 2024 is calculated as:

YoY EPS Growth (Q: Jun. 2024 )
=(Earnings per Share (Diluted) (Q: Jun. 2024 )-Earnings per Share (Diluted) (Q: Jun. 2023 )) / | Earnings per Share (Diluted) (Q: Jun. 2023 )) |
=(0.122-0.066)/ | 0.066 |
=84.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baird Medical Investment Holdings YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Baird Medical Investment Holdings's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Baird Medical Investment Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baird Medical Investment Holdings Ltd (NAS:BDMD) » Definitions » YoY EPS Growth
Comparable Companies
LUNG OM ELMD INGN MASS QSI QTRX TLSI CATX CVRX ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE
Traded in Other Exchanges
N/A
Address
No.15 Rongtong Street, Room 202, 2nd Floor, Baide Building, Building 11, Yuexiu, Guangzhou, CHN
Website
Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.